Skip to main
  1. Stocks
  2. Sol-Gel Technologies
  3. Forecast
SLGL

Sol-Gel Technologies (SLGL) Stock Forecast & Price Target

Sol-Gel Technologies (SLGL) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Sol-Gel Technologies is attractive because its lead asset, SGT-610, addresses a severe unmet need in Gorlin syndrome, where patients can develop dozens or even hundreds of BCCs and rely on repeated, painful, costly surgeries with no approved therapy. The upcoming Phase 3 top-line readout, in a 113-patient randomized, double-blind, vehicle-controlled study with 102 completers, is a major catalyst, and the bullish case is strengthened by a focused PTCH1+ population, a prior post hoc signal showing 48% fewer new BCCs, and a potential U.S. population of roughly 11-12K diagnosed patients. Financially, the company’s ~$52.8M cash and marketable securities, ~$33.1M March 2026 financing, and additional TWYNEO/EPSOLAY partnership royalties support development while preserving optionality for long-term upside.

Bears say

Sol-Gel Technologies is facing a fundamentally weak investment case because its SGT-610 Phase 3 is essentially a redo of PellePharm’s failed 2021 study, which missed statistical significance on the primary endpoint with p=0.73. The company also bought the asset for only about $5M upfront in 2023, underscoring limited prior conviction, while the current trial remains exposed to replication risk, highly variable lesion counts, and an endpoint that may not deliver a durable treatment effect even if it succeeds statistically. Commercially, approval would still not ensure meaningful revenue because physician adoption and reimbursement are uncertain, and the company remains concentrated in the United States.

Sol-Gel Technologies (SLGL) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sol-Gel Technologies and is not a guaranteed prediction by Public.com or investment advice.

Sol-Gel Technologies (SLGL) Analyst Forecast & Price Prediction

Get the latest Sol-Gel Technologies (SLGL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Sol-Gel Technologies (SLGL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sol-Gel Technologies (SLGL) Forecast

Analysts have given Sol-Gel Technologies (SLGL) a Buy based on their latest research and market trends.

According to 2 analysts, Sol-Gel Technologies (SLGL) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $197.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $197.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sol-Gel Technologies (SLGL)


Sol-Gel Technologies (SLGL) Analyst Forecast & Price Prediction

Get the latest Sol-Gel Technologies (SLGL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Sol-Gel Technologies (SLGL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover SLGL stock data and trends